Rui Zhang

11.1k total citations · 2 hit papers
290 papers, 7.8k citations indexed

About

Rui Zhang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rui Zhang has authored 290 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 218 papers in Molecular Biology, 152 papers in Cancer Research and 32 papers in Oncology. Recurrent topics in Rui Zhang's work include Cancer-related molecular mechanisms research (112 papers), MicroRNA in disease regulation (71 papers) and RNA modifications and cancer (66 papers). Rui Zhang is often cited by papers focused on Cancer-related molecular mechanisms research (112 papers), MicroRNA in disease regulation (71 papers) and RNA modifications and cancer (66 papers). Rui Zhang collaborates with scholars based in China, United States and Canada. Rui Zhang's co-authors include Angang Yang, Xiang Zhang, Lintao Jia, Lei Wang, Jing Zhao, Libo Yao, Jin‐Shui Zhu, Bo Yan, Jinpu Yu and Tian Xia and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Rui Zhang

273 papers receiving 7.8k citations

Hit Papers

RNA m6A methylation orchestrates cancer growth and metast... 2020 2026 2022 2024 2021 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
    2021 313 citations Angang Yang, Rui Zhang et al. Nature Communications profile →
  2. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes
    2020 270 citations Cefan Zhou, Rui Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Zhang China 49 5.9k 4.1k 972 681 672 290 7.8k
Chao Lü United States 40 5.5k 0.9× 3.0k 0.7× 1.0k 1.0× 747 1.1× 720 1.1× 112 8.4k
Yang Wang China 45 8.1k 1.4× 3.8k 0.9× 793 0.8× 430 0.6× 451 0.7× 225 9.5k
Tiebang Kang China 51 6.3k 1.1× 3.4k 0.8× 2.4k 2.5× 712 1.0× 832 1.2× 156 8.9k
Qihong Huang China 45 5.9k 1.0× 3.8k 0.9× 972 1.0× 301 0.4× 478 0.7× 111 7.5k
Yongguang Tao China 43 6.1k 1.0× 4.0k 1.0× 1.3k 1.3× 2.1k 3.1× 860 1.3× 170 8.3k
Jueheng Wu China 50 4.5k 0.8× 2.6k 0.6× 1.2k 1.2× 407 0.6× 619 0.9× 101 6.2k
Hongjuan Cui China 42 4.9k 0.8× 1.9k 0.5× 1.6k 1.7× 572 0.8× 955 1.4× 254 7.8k
Jianren Gu China 48 8.1k 1.4× 5.3k 1.3× 2.1k 2.1× 586 0.9× 800 1.2× 150 11.0k
David M. Feldser United States 27 8.1k 1.4× 6.9k 1.7× 1.8k 1.8× 799 1.2× 814 1.2× 42 11.1k

Countries citing papers authored by Rui Zhang

Since Specialization
Citations

This map shows the geographic impact of Rui Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Zhang more than expected).

Fields of papers citing papers by Rui Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Zhang. The network helps show where Rui Zhang may publish in the future.

Co-authorship network of co-authors of Rui Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Zhang. A scholar is included among the top collaborators of Rui Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Zhang. Rui Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qian, Ke Gao, Ma Zhou, et al.. (2025). Epigenetic Regulation of Aging and its Rejuvenation. MedComm. 6(9). e70369–e70369. 3 indexed citations
2.
3.
4.
Zhang, Xue, Chen Jiang, Yin Yuan, et al.. (2024). Design and characterization of Glypican-3 targeted liposomes with cantharidin encapsulation for hepatocellular carcinoma treatment. Journal of Drug Delivery Science and Technology. 99. 105934–105934. 3 indexed citations
5.
Liu, Xingxing, Guangyu Shi, Lidan Li, Rui Zhang, & Jinli Qiao. (2024). Detection and molecular typing of epidemic Brucella strains among camels, sheep, and cattle in Xinjiang, China. PLoS ONE. 19(10). e0311933–e0311933. 1 indexed citations
6.
Zhang, Rui, et al.. (2024). LncRNA HAGLROS promotes breast cancer evolution through miR-135b-3p/COL10A1 axis and exosome-mediated macrophage M2 polarization. Cell Death and Disease. 15(8). 633–633. 25 indexed citations
7.
Liu, Qinfeng, Xin Zhang, Rui Zhang, et al.. (2024). TRPM channels in human cancers: regulatory mechanism and therapeutic prospects. Biomarker Research. 12(1). 152–152. 1 indexed citations
8.
Pan, Yangyang, Meng Wang, Libin Wang, et al.. (2023). LncRNA MEG3 regulates ASK1/JNK axis-mediated apoptosis and autophagy via sponging miR-23a in granulosa cells of yak tertiary follicles. Cellular Signalling. 107. 110680–110680. 6 indexed citations
9.
Chen, Baolin, Li Li, Jiaxing Zhang, et al.. (2023). High doses of rosuvastatin induce impaired branched‐chain amino acid catabolism and lead to insulin resistance. Experimental Physiology. 108(7). 961–974. 7 indexed citations
10.
Xu, Jiahui, Xiaoli Yang, Qiaodan Deng, et al.. (2021). TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer. Nature Communications. 12(1). 4413–4413. 50 indexed citations
11.
Lu, Yuan, Jing Huang, Yuan Wang, et al.. (2021). EGFR-specific single-chain variable fragment antibody-conjugated Fe3O4/Au nanoparticles as an active MRI contrast agent for NSCLC. Magnetic Resonance Materials in Physics Biology and Medicine. 34(4). 581–591. 17 indexed citations
12.
Zhang, Zhifa, Jiangjun Liu, Xuelin Zhao, et al.. (2020). Long Noncoding RNA SERTAD2-3 Inhibits Osteosarcoma Proliferation and Migration by Competitively Binding miR-29c. Genetic Testing and Molecular Biomarkers. 24(2). 67–72. 5 indexed citations
13.
Song, Shuai, Rui Zhang, Long Chen, et al.. (2019). EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation. Journal of Molecular and Cellular Cardiology. 135. 119–133. 64 indexed citations
14.
Zhang, Rui, Fan Zhang, Zeguo Sun, et al.. (2019). LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY. Cancer Research. 79(17). 4453–4465. 33 indexed citations
15.
Song, Shuai, Rui Zhang, Wei Cao, et al.. (2018). Foxm1 is a critical driver of TGF‐β‐induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter. Journal of Cellular Physiology. 234(6). 9052–9064. 54 indexed citations
16.
Wang, Xi, Guojun Zhang, Zhe Cheng, et al.. (2018). Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137. Genetic Testing and Molecular Biomarkers. 22(6). 333–342. 61 indexed citations
17.
18.
Wang, Yuan, Jian Zhang, Mingxiang Ye, et al.. (2016). HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth. Oncotarget. 7(17). 23594–23607. 9 indexed citations
19.
Zhang, Rui, Bo Pang, Tao Xin, et al.. (2015). Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma. Molecular Neurobiology. 53(3). 1452–1460. 65 indexed citations
20.
Sun, Yu, Rui Zhang, Minjie Wang, et al.. (2012). SOX2 Autoantibodies As Noninvasive Serum Biomarker for Breast Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 21(11). 2043–2047. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chao Lü Breakdown of academic impact, for papers by Yang Wang Breakdown of academic impact, for papers by Tiebang Kang Breakdown of academic impact, for papers by Qihong Huang Breakdown of academic impact, for papers by Yongguang Tao Breakdown of academic impact, for papers by Jueheng Wu Breakdown of academic impact, for papers by Hongjuan Cui Breakdown of academic impact, for papers by Jianren Gu Breakdown of academic impact, for papers by David M. Feldser
Rankless by CCL
2026